CD86 and colonic neoplasm: We analyzed the number of CD86+ (an M1 marker) and CD206+ (an M2 marker) macrophages in colon tumor tissues and revealed that S100A4Smad4-/- mice had reduced M1 phenotype and enhanced M2 phenotype (Figure 4A).